{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:08:11Z","timestamp":1761581291188,"version":"3.41.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,3,14]],"date-time":"2015-03-14T00:00:00Z","timestamp":1426291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s10552-015-0554-z","type":"journal-article","created":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T13:54:04Z","timestamp":1426254844000},"page":"821-830","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The impact of obesity on prostate cancer recurrence observed after exclusion of diabetics"],"prefix":"10.1007","volume":"26","author":[{"given":"Ilir","family":"Agalliu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lagu","family":"Androga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Siev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaonan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard D.","family":"Strickler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Ghavamian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,14]]},"reference":[{"key":"554_CR1","unstructured":"American Cancer Society (ACS) (2014) Cancer facts & figures\u00a02014. Atlanta, GA"},{"key":"554_CR2","unstructured":"Howlader N, Noone A, Krapcho M, Garshell J, Miller D, Altekruse S et al (2014) SEER cancer statistics review, 1975\u20132011. National Cancer Institute, Bethesda, MD. http:\/\/seer.cancer.gov\/csr\/1975_2011\/ . Based on November 2013 SEER data submission, posted to the SEER web site, April 2014"},{"issue":"1","key":"554_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64(1):9\u201329","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"554_CR4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","volume":"343","author":"P Lichtenstein","year":"2000","unstructured":"Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M et al (2000) Environmental and heritable factors in the causation of cancer\u2014analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343(2):78\u201385","journal-title":"N Engl J Med"},{"issue":"4","key":"554_CR5","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0022-5347(17)40078-4","volume":"143","author":"HB Carter","year":"1990","unstructured":"Carter HB, Piantadosi S, Isaacs JT (1990) Clinical evidence for and implications of the multistep development of prostate cancer. J Urol 143(4):742\u2013746","journal-title":"J Urol"},{"issue":"8","key":"554_CR6","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10552-006-0049-z","volume":"17","author":"RJ MacInnis","year":"2006","unstructured":"MacInnis RJ, English DR (2006) Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 17(8):989\u20131003","journal-title":"Cancer Causes Control"},{"issue":"10","key":"554_CR7","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1158\/1055-9965.EPI-06-0477","volume":"15","author":"Z Gong","year":"2006","unstructured":"Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW et al (2006) Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomark Prev 15(10):1977\u20131983","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"554_CR8","doi-asserted-by":"crossref","first-page":"s843","DOI":"10.1093\/ajcn\/86.3.843S","volume":"86","author":"AW Hsing","year":"2007","unstructured":"Hsing AW, Sakoda LC, Chua S Jr (2007) Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr 86(3):s843\u2013s857","journal-title":"Am J Clin Nutr"},{"key":"554_CR9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/epirev\/mxm006","volume":"29","author":"SJ Freedland","year":"2007","unstructured":"Freedland SJ, Platz EA (2007) Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev 29:88\u201397","journal-title":"Epidemiol Rev"},{"issue":"4","key":"554_CR10","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1158\/1940-6207.CAPR-10-0229","volume":"4","author":"Y Cao","year":"2011","unstructured":"Cao Y, Ma J (2011) Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res 4(4):486\u2013501","journal-title":"Cancer Prev Res"},{"key":"554_CR11","doi-asserted-by":"crossref","unstructured":"Chalfin HJ, Lee SB, Jeong BC, Freedland SJ, Feng Z, Trock BJ et al (2014) Obesity and long-term survival after radical prostatectomy. J Urol\u00a0192(4):1100\u20134. doi: 10.1016\/j.juro.2014.04.086","DOI":"10.1016\/j.juro.2014.04.086"},{"issue":"2","key":"554_CR12","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s12032-013-0829-8","volume":"31","author":"MB Hu","year":"2014","unstructured":"Hu MB, Xu H, Bai PD, Jiang HW, Ding Q (2014) Obesity has multifaceted impact on biochemical recurrence of prostate cancer: a dose\u2013response meta-analysis of 36,927 patients. Med Oncol 31(2):829","journal-title":"Med Oncol"},{"issue":"12","key":"554_CR13","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","volume":"8","author":"M Pollak","year":"2008","unstructured":"Pollak M (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8(12):915\u2013928","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"554_CR14","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.tem.2006.08.006","volume":"17","author":"AG Renehan","year":"2006","unstructured":"Renehan AG, Frystyk J, Flyvbjerg A (2006) Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab 17(8):328\u2013336","journal-title":"Trends Endocrinol Metab"},{"key":"554_CR15","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1158\/1055-9965.EPI-07-2686","volume":"17","author":"MJ Gunter","year":"2008","unstructured":"Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Manson JE, Li J et al (2008) A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer. Cancer Epidemiol Biomark Prev 17:921\u2013929","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"554_CR16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/jnci\/djn415","volume":"101","author":"MJ Gunter","year":"2009","unstructured":"Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE et al (2009) Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 101(1):48\u201360","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"554_CR17","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1158\/1055-9965.EPI-06-0410","volume":"15","author":"JS Kasper","year":"2006","unstructured":"Kasper JS, Giovannucci E (2006) A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomark Prev 15(11):2056\u20132062","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"Suppl 1","key":"554_CR18","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1007\/s00592-012-0439-5","volume":"49","author":"F Zhang","year":"2012","unstructured":"Zhang F, Yang Y, Skrip L, Hu D, Wang Y, Wong C et al (2012) Diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case-control and 25 cohort studies. Acta Diabetol 49(Suppl 1):S235\u2013S246","journal-title":"Acta Diabetol"},{"issue":"2","key":"554_CR19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2337\/dc11-1313","volume":"35","author":"CJ Currie","year":"2012","unstructured":"Currie CJ, Poole CD, Jenkins-Jones S, Gale EA, Johnson JA, Morgan CL (2012) Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival. Diabetes Care 35(2):299\u2013304","journal-title":"Diabetes Care"},{"issue":"1","key":"554_CR20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11255-012-0306-x","volume":"45","author":"JJ Oh","year":"2013","unstructured":"Oh JJ, Hong SK, Lee S, Sohn SJ, Lee SE (2013) Diabetes mellitus is associated with short prostate-specific antigen doubling time after radical prostatectomy. Int Urol Nephrol 45(1):121\u2013127","journal-title":"Int Urol Nephrol"},{"key":"554_CR21","doi-asserted-by":"crossref","unstructured":"Rieken M, Kluth LA, Xylinas E, Fajkovic H, Becker A, Karakiewicz PI et al (2014) Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer. World J Urol 32(4):999\u20131005. doi: 10.1007\/s00345-013-1171-7","DOI":"10.1007\/s00345-013-1171-7"},{"issue":"6","key":"554_CR22","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","volume":"35","author":"SE Inzucchi","year":"2012","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M et al (2012) Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35(6):1364\u20131379","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"554_CR23","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.2337\/dc14-S014","volume":"37","author":"American Diabetes Association","year":"2014","unstructured":"American Diabetes Association (2014) Standards of medical care in diabetes\u20142014. Diabetes Care 37(Suppl 1):S14\u2013S80","journal-title":"Diabetes Care"},{"key":"554_CR24","doi-asserted-by":"crossref","unstructured":"Ligibel JA, Strickler HD (2013) Obesity and its impact on breast cancer: tumor incidence, recurrence, survival, and possible interventions. Am Soc Clin Oncol Educ Book. 2013:52-9. doi: 10.1200\/EdBook_AM.2013.33.52","DOI":"10.1200\/EdBook_AM.2013.33.52"},{"key":"554_CR25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR (1972) Regression models and life tables (with discussion). J R Stat Soc B 34:187\u2013220","journal-title":"J R Stat Soc B"},{"key":"554_CR26","volume-title":"Applied survival analysis","author":"DW Hosmer","year":"1999","unstructured":"Hosmer DW, Lemeshow S (1999) Applied survival analysis. Wiley, New York"},{"issue":"3","key":"554_CR27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.2009.2014","volume":"303","author":"KM Flegal","year":"2010","unstructured":"Flegal KM, Carroll MD, Ogden CL, Curtin LR (2010) Prevalence and trends in obesity among US adults, 1999\u20132008. JAMA 303(3):235\u2013241","journal-title":"JAMA"},{"key":"554_CR28","unstructured":"Ogden CL, Carrol MD, Kit BK, Flegal KM (2012) Prevalence of obesity in the United States, 2009\u20132010. In: National Center for Health Statistics (NCHS) Data Brief 2012, vol 82, pp 1\u20137"},{"issue":"6","key":"554_CR29","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1007\/s10900-014-9870-6","volume":"39","author":"RJ Wong","year":"2014","unstructured":"Wong RJ, Chou C, Ahmed A (2014) Long Term Trends and Racial\/Ethnic Disparities in the Prevalence of Obesity. J Community Health 39(6):1150\u20131160","journal-title":"J Community Health"},{"issue":"1","key":"554_CR30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/pcan.2012.32","volume":"16","author":"R Asmar","year":"2013","unstructured":"Asmar R, Beebe-Dimmer JL, Korgavkar K, Keele GR, Cooney KA (2013) Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy. Prostate Cancer Prostatic Dis 16(1):62\u201366","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"554_CR31","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.urology.2005.05.040","volume":"66","author":"WW Bassett","year":"2005","unstructured":"Bassett WW, Cooperberg MR, Sadetsky N, Silva S, DuChane J, Pasta DJ et al (2005) Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urology 66(5):1060\u20131065","journal-title":"Urology"},{"issue":"11","key":"554_CR32","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S1470-2045(08)70235-3","volume":"9","author":"J Ma","year":"2008","unstructured":"Ma J, Li H, Giovannucci E, Mucci L, Qiu W, Nguyen PL, Gaziano JM, Pollak M, Stampfer MJ (2008) Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol 9(11):1039\u20131047","journal-title":"Lancet Oncol"},{"issue":"18","key":"554_CR33","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/jnci\/djp260","volume":"101","author":"D Albanes","year":"2009","unstructured":"Albanes D, Weinstein SJ, Wright ME, Mannisto S, Limburg PJ, Snyder K, Virtamo J (2009) Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer. J Natl Cancer Inst 101(18):1272\u20131279","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"554_CR34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/pros.20852","volume":"69","author":"ME Cox","year":"2009","unstructured":"Cox ME, Gleave ME, Zakikhani M, Bell RH, Piura E, Vickers E, Cunningham M, Larsson O, Fazli L, Pollak M (2009) Insulin receptor expression by human prostate cancers. Prostate 69(1):33\u201340","journal-title":"Prostate"},{"key":"554_CR35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000092969","volume":"13","author":"KE Visser de","year":"2006","unstructured":"de Visser KE, Coussens LM (2006) The inflammatory tumor microenvironment and its impact on cancer development. Contrib Microbiol 13:118\u2013137","journal-title":"Contrib Microbiol"},{"issue":"12","key":"554_CR36","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1515\/BC.2009.144","volume":"390","author":"PA Gerber","year":"2009","unstructured":"Gerber PA, Hippe A, Buhren BA, Muller A, Homey B (2009) Chemokines in tumor-associated angiogenesis. Biol Chem 390(12):1213\u20131223","journal-title":"Biol Chem"},{"issue":"6","key":"554_CR37","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140(6):883\u2013899","journal-title":"Cell"},{"issue":"1","key":"554_CR38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.semcancer.2005.07.006","volume":"16","author":"A Ben-Baruch","year":"2006","unstructured":"Ben-Baruch A (2006) Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Semin Cancer Biol 16(1):38\u201352","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"554_CR39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrc1782","volume":"6","author":"KE Visser de","year":"2006","unstructured":"de Visser KE, Eichten A, Coussens LM (2006) Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6(1):24\u201337","journal-title":"Nat Rev Cancer"},{"issue":"7\u20138","key":"554_CR40","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1600-0463.2004.apm11207-0808.x","volume":"112","author":"MM Rosenkilde","year":"2004","unstructured":"Rosenkilde MM, Schwartz TW (2004) The chemokine system\u2014a major regulator of angiogenesis in health and disease. Apmis 112(7\u20138):481\u2013495","journal-title":"Apmis"},{"issue":"4","key":"554_CR41","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrc2090","volume":"7","author":"AM Marzo De","year":"2007","unstructured":"De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG (2007) Inflammation in prostate carcinogenesis. Nat Rev Cancer 7(4):256\u2013269","journal-title":"Nat Rev Cancer"},{"issue":"5 Pt 2","key":"554_CR42","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1097\/01.ju.0000142058.99614.ff","volume":"172","author":"WG Nelson","year":"2004","unstructured":"Nelson WG, De Marzo AM, DeWeese TL, Isaacs WB (2004) The role of inflammation in the pathogenesis of prostate cancer. J Urol 172(5 Pt 2):S6\u2013S11 discussion S11\u201312","journal-title":"J Urol"},{"issue":"4","key":"554_CR43","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000020161","volume":"37","author":"PH Schatteman","year":"2000","unstructured":"Schatteman PH, Hoekx L, Wyndaele JJ, Jeuris W, Van Marck E (2000) Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density. Eur Urol 37(4):404\u2013412","journal-title":"Eur Urol"},{"issue":"6","key":"554_CR44","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s00345-013-1065-8","volume":"31","author":"JC Klink","year":"2013","unstructured":"Klink JC, Banez LL, Gerber L, Lark A, Vollmer RT, Freedland SJ (2013) Intratumoral inflammation is associated with more aggressive prostate cancer. World J Urol 31(6):1497\u20131503","journal-title":"World J Urol"},{"issue":"19 Pt 1","key":"554_CR45","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1158\/1078-0432.CCR-04-1977","volume":"11","author":"SS Strom","year":"2005","unstructured":"Strom SS, Wang X, Pettaway CA, Logothetis CJ, Yamamura Y, Do KA, Babaian RJ, Troncoso P (2005) Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy. Clin Cancer Res 11(19 Pt 1):6889\u20136894","journal-title":"Clin Cancer Res"},{"issue":"4","key":"554_CR46","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1158\/1940-6207.CAPR-10-0257","volume":"4","author":"CE Joshu","year":"2011","unstructured":"Joshu CE, Mondul AM, Menke A, Meinhold C, Han M, Humphreys EB, Freedland SJ, Walsh PC, Platz EA (2011) Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era. Cancer Prev Res 4(4):544\u2013551","journal-title":"Cancer Prev Res"},{"issue":"4","key":"554_CR47","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2337\/dc11-1299","volume":"35","author":"Diabetes Prevention Program Research Group","year":"2012","unstructured":"Diabetes Prevention Program Research Group (2012) Long-term safety, tolerability, and weight loss associated with metformin in the diabetes prevention program outcomes study. Diabetes Care 35(4):731\u2013737","journal-title":"Diabetes Care"},{"issue":"5","key":"554_CR48","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/MED.0000000000000095","volume":"21","author":"SK Malin","year":"2014","unstructured":"Malin SK, Kashyap SR (2014) Effects of metformin on weight loss: potential mechanisms. Curr Opin Endocrinol Diabetes Obes 21(5):323\u2013329","journal-title":"Curr Opin Endocrinol Diabetes Obes"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-015-0554-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-015-0554-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-015-0554-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T23:29:12Z","timestamp":1747783752000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-015-0554-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,14]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["554"],"URL":"https:\/\/doi.org\/10.1007\/s10552-015-0554-z","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"type":"print","value":"0957-5243"},{"type":"electronic","value":"1573-7225"}],"subject":[],"published":{"date-parts":[[2015,3,14]]}}}